34th International Symposium on ALS/MND

From 6 to 8 December 2023, more than 1300 people from all…

Words Floor Ooms.Published December 22, 2023
34th International Symposium on ALS/MND

From 6 to 8 December 2023, more than 1300 people from all over the world gathered in Basel, Switserland for the 34th edition of the International Symposium on ALS/MND. After three online editions, this year the MND community could come together again in person.  

MND Association’s International Symposium on ALS/MND is the largest medical and scientific conference dedicated to ALS and MND research. Clinicians, researchers, health and social care professionals and even patient fellows came together to discuss the newest understanding of ALS and MND, make new connections and form new partnerships.

The three days were filled with keynote lectures, sessions on various topics from clinical trials to biomarkers and almost 400 poster presentations. One of the highlights of the Symposium was the closing session, which brought a patient with FUS-ALS trialing the drug Jacifusen onto the stage. The patient has the rare FUS mutation, which leads to an aggressive form of the disease: she wasn’t able to walk anymore and ended up in a coma. After taking the drug, she was now able to stand on the stage herself.  

Read more about the Symposium here.

 


Share

Related news

Results ADORE study: no effect of medication
Results ADORE study: no effect of medication
The pharmaceutical company Ferrer has announced their first results of the ADORE […]
3FM Serious Request takes action for ALS Foundation Netherlands
3FM Serious Request takes action for ALS Foundation Netherlands
3FM Serious Request is taking action for the ALS Foundation Netherlands during […]
Over 200 patients participate in Lighthouse II study worldwide
Over 200 patients participate in Lighthouse II study worldwide
The Lighthouse II study is a phase 3 clinical trial that compares […]
ENCALS consensus statement on NurOwn
ENCALS consensus statement on NurOwn
Background Given the interest around the use of stem cells in ALS, […]